29633

0

CHANDAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CHANDAN HEALTHCARE LTD Share Price Today

CHANDAN HEALTHCARE LTD is currently trading at ₹236.5, down by ₹0.19 from the previous close. The stock touched an intraday high of ₹242.00 and a low of ₹231.00 during the latest trading session. Over the past one year, CHANDAN HEALTHCARE LTD has delivered a return of 31.42%, while the stock has declined 6.6% in the last one month.

CHANDAN HEALTHCARE LTD performance

Today’s low Today’s high
₹ 231.00 ₹ 242.00
₹ 237.05
52 week low 52 week high
₹ 179.00 ₹ 358.00
₹ 237.05
Open Price ₹ 231.00
Prev. Close ₹ 236.70
Volume (Shares) 17600.00
Total traded value ₹ 41.72
Upper Circuit ₹ 284.00
Lower Circuit ₹ 189.40
info

Investment Returns

Over 1 Month -6.60% Over 3 Months -10.00% Over 6 Months -26.26% Over 1 Year 31.42%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CHANDAN HEALTHCARE LTD fundamentals


  • Market cap (Cr) 579.60
  • P/E Ratio (TTM) 22.85
  • Beta 0.98
  • Book Value / share 68.00
  • Return on equity 25.75%
  • EPS (TTM) 11.19
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 6.82
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

CHANDAN HEALTHCARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 44.77
Operating Expense 37.16
Net Profit 6.82
Net Profit Margin (%) 15.23
Earnings Per Share (EPS) 2.79
EBITDA 12.66
Effective Tax Rate (%) 23.79
Particulars DEC 2025 (Values in Cr)
Revenue 35.70
Operating Expense 29.00
Net Profit 3.96
Net Profit Margin (%) 11.09
Earnings Per Share (EPS) 1.62
EBITDA 8.62
Effective Tax Rate (%) 25.37
Particulars SEP 2025 (Values in Cr)
Revenue 38.09
Operating Expense 29.00
Net Profit 7.28
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 2.98
EBITDA 13.28
Effective Tax Rate (%) 25.86
Particulars JUN 2025 (Values in Cr)
Revenue 38.09
Operating Expense 0.00
Net Profit 7.28
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 2.98
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 37.05
Operating Expense 30.07
Net Profit 6.42
Net Profit Margin (%) 17.32
Earnings Per Share (EPS) 2.92
EBITDA 12.29
Effective Tax Rate (%) 27.78
Particulars MAR 2026 (Values in Cr)
Revenue 156.65
Operating Expense 124.16
Net Profit 25.34
Net Profit Margin (%) 16.17
Earnings Per Share (EPS) 10.36
EBITDA 47.83
Effective Tax Rate (%) 25.25
Particulars MAR 2025 (Values in Cr)
Revenue 129.16
Operating Expense 103.05
Net Profit 20.78
Net Profit Margin (%) 16.08
Earnings Per Share (EPS) 10.10
EBITDA 38.16
Effective Tax Rate (%) 26.23
Particulars MAR 2024 (Values in Cr)
Revenue 99.86
Operating Expense 79.91
Net Profit 16.02
Net Profit Margin (%) 16.04
Earnings Per Share (EPS) 8.01
EBITDA 26.43
Effective Tax Rate (%) 23.61
Particulars MAR 2023 (Values in Cr)
Revenue 75.83
Operating Expense 70.66
Net Profit 4.04
Net Profit Margin (%) 5.32
Earnings Per Share (EPS) 2.02
EBITDA 9.39
Effective Tax Rate (%) 23.14
Particulars MAR 2022 (Values in Cr)
Revenue 71.60
Operating Expense 72.52
Net Profit -1.37
Net Profit Margin (%) -1.91
Earnings Per Share (EPS) -0.69
EBITDA 2.92
Effective Tax Rate (%) -92.95
Particulars MAR 2025 (Values in Cr)
Book Value / Share 50.14
ROE % 28.72
ROCE % 28.82
Total Debt to Total Equity 0.51
EBITDA Margin 18.86
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.58
ROE % 47.79
ROCE % 36.97
Total Debt to Total Equity 0.84
EBITDA Margin 15.64
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.65
ROE % 14.02
ROCE % 15.89
Total Debt to Total Equity 0.74
EBITDA Margin 6.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.97
ROE % -4.55
ROCE % 1.52
Total Debt to Total Equity 0.69
EBITDA Margin 2.18
Particulars MAR 2025 (Values in Cr)
Book Value / Share 49.37
ROE % 25.75
ROCE % 27.64
Total Debt to Total Equity 0.39
EBITDA Margin 29.54
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.33
ROE % 47.59
ROCE % 39.16
Total Debt to Total Equity 0.68
EBITDA Margin 26.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.33
ROE % 16.40
ROCE % 17.63
Total Debt to Total Equity 0.65
EBITDA Margin 12.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.30
ROE % -5.76
ROCE % 2.56
Total Debt to Total Equity 0.61
EBITDA Margin 4.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.47
ROE % 3.35
ROCE % 9.03
Total Debt to Total Equity 0.58
EBITDA Margin 8.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.20
Total Assets 210.61
Total Liabilities 210.61
Total Equity 126.40
Share Outstanding 2
Price to Book Ratio 3.67
Return on Assets (%) 10.52
Return on Capital (%) 12.7
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.89
Total Assets 118.07
Total Liabilities 118.07
Total Equity 43.62
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 13.78
Return on Capital (%) 20.47
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.04
Total Assets 98.13
Total Liabilities 98.13
Total Equity 30.06
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 3.43
Return on Capital (%) 6.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 81.53
Total Liabilities 81.53
Total Equity 26.47
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -1.36
Return on Capital (%) -2.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.87
Total Assets 64.88
Total Liabilities 64.88
Total Equity 23.97
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 1.36
Return on Capital (%) 2.35
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.03
Total Assets 176.90
Total Liabilities 176.90
Total Equity 120.71
Share Outstanding 2
Price to Book Ratio 3.67
Return on Assets (%) 11.74
Return on Capital (%) 13.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 93.11
Total Liabilities 93.11
Total Equity 40.66
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 17.20
Return on Capital (%) 22.96
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 69.68
Total Liabilities 69.68
Total Equity 26.65
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 5.80
Return on Capital (%) 9.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.96
Total Assets 59.49
Total Liabilities 59.49
Total Equity 22.60
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) -2.30
Return on Capital (%) -3.62
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.44
Total Assets 56.18
Total Liabilities 56.18
Total Equity 24.94
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 1.45
Return on Capital (%) 2.12
Particulars MAR 2025 (Values in Cr)
Net Income 32.06
Cash from Operations -20.50
Cash from Investing -35.74
Cash from Financing 67.10
Net change in Cash 2.30
Free Cash Flow 18.20
Particulars MAR 2024 (Values in Cr)
Net Income 21.46
Cash from Operations 6.02
Cash from Investing -14.82
Cash from Financing 15.56
Net change in Cash 1.85
Free Cash Flow 25.56
Particulars MAR 2023 (Values in Cr)
Net Income 5.01
Cash from Operations 5.61
Cash from Investing -6.48
Cash from Financing 2.46
Net change in Cash 0.46
Free Cash Flow 10.89
Particulars MAR 2022 (Values in Cr)
Net Income -1.06
Cash from Operations 6.21
Cash from Investing -10.74
Cash from Financing 3.47
Net change in Cash -1.16
Free Cash Flow 12.85
Particulars MAR 2025 (Values in Cr)
Net Income 28.16
Cash from Operations -11.30
Cash from Investing -35.79
Cash from Financing 59.98
Net change in Cash 5.49
Free Cash Flow 27.17
Particulars MAR 2024 (Values in Cr)
Net Income 20.96
Cash from Operations 9.43
Cash from Investing -15.36
Cash from Financing 8.50
Net change in Cash -1.00
Free Cash Flow 28.59
Particulars MAR 2023 (Values in Cr)
Net Income 5.26
Cash from Operations 7.72
Cash from Investing -6.18
Cash from Financing -2.00
Net change in Cash -3.45
Free Cash Flow 12.69
Particulars MAR 2022 (Values in Cr)
Net Income -0.71
Cash from Operations 7.49
Cash from Investing -9.51
Cash from Financing -1.83
Net change in Cash -3.85
Free Cash Flow 14.05
Particulars MAR 2021 (Values in Cr)
Net Income 1.48
Cash from Operations -5.95
Cash from Investing 7.44
Cash from Financing -0.50
Net change in Cash 0.31
Free Cash Flow -5.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8303.55 61.03 12.60 119392.31 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 54.56 24.69 2.97 102.26 40.75 77.00
SHREE PACETRONIX LTD. 141.75 16.92 2.98 53.15 66.10 283.15
TRANSGENE BIOTEK LTD. 3.11 0.00 2.81 23.56 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8303.55 79.53 11.98 119392.31 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.80 0.00 -9.44 28.98 30.30 57.48
KOVAI MEDICAL CENTER & HO 5378.20 24.07 4.45 5883.75 5010.00 6725.00

CHANDAN HEALTHCARE LTD shareholding pattern

Holding
45.41%
49.54%
5.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

CHANDAN HEALTHCARE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
237.05 0.14 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 237.90
  • 26 Days 242.00
  • 10 Days 238.00
  • 50 Days 247.80
  • 12 Days 238.40
  • 100 Days 256.30
  • 20 Days 240.40
  • 200 Days 250.30
238.25 PIVOT
First Support 234.00 First Resistance 240.95 Second Support 231.30 Second Resistance 245.20 Third Support 227.05 Third Resistance 247.90
RSI 45.83 ADX 29.17 MACD -3.60 Williams % R -42.90 Commodity Channel Index (CCI) -24.00
Date 2026-06-05 Week 28533.00 Same Day 14400.00 Month 19861.00
1 Year 0.98 3 Year 0.89
Over 1 Month
-6.60% down
Over 1 Year
31.42% down
Over 3 Months
-10.00% down
Over 3 Years
0.00% down
Over 6 Months
-26.26% down
Over 5 Years
0.00% down

CHANDAN HEALTHCARE LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Chandan Healthcare Ltd?

Answer Field

Chandan Healthcare Ltd share price is for NSE ₹ 236.50 & for BSE ₹ 0.00 as on Jun 08 2026 03:27 PM.

What is the Market Cap of Chandan Healthcare Ltd Share?

Answer Field

The market cap of Chandan Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 08 2026 03:27 PM.

What is the 52 Week High and Low of Chandan Healthcare Ltd?

Answer Field

The 52 Week High and Low of Chandan Healthcare Ltd for NSE is ₹ 358.00 and ₹ 179.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Chandan Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 31.42%.

What is the P/E Ratio of Chandan Healthcare Ltd Share?

Answer Field

As on Jun 08 2026 03:27 PM the price-to-earnings (PE) ratio for Chandan Healthcare Ltd share is 22.85.

What is the PB ratio of Chandan Healthcare Ltd Share?

Answer Field

As on Jun 08 2026 03:27 PM, the price-to-book (PB) ratio for Chandan Healthcare Ltd share is 68.00.

How to Buy Chandan Healthcare Ltd Share?

Answer Field

You can trade in Chandan Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Chandan Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Chandan Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Chandan Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|